A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

Does GLP-1RA use impact the risk of thyroid cancer? GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular ...

Trading under the symbol ‘MTSR’, the company said it plans to use the funds to advance its glucagon-like peptide-1 receptor agonist (GLP-1RA) asset MET-097i through a Phase III trial.

Glucagon-like peptide-1 receptor agonists (GLP-1RA) drugs like Ozempic and Wegovy are called “miracle drugs” by some pharmacists for their ability to help those with diabetes to lose weight. The drugs ...

Over the past decade, there has been a substantial increase in GLP-1RA use, and some research has highlighted its gastrointestinal side effects. Considering the wide use of GLP-1RAs, it is ...

The largest analysis to date of patients taking GLP-1 receptor agonists (GLP-1RAs) has investigated their effects on nearly 175 diseases, and found that compared to three other classes of diabetes ...

Efruxifermin (EFX) with GLP-1RA significantly reduces hepatic fat fraction and improves fibrosis in MASH and T2D patients. The study involved 31 patients over 12 weeks, showing EFX enhances GLP ...

“Our approach has allowed us to build a comprehensive atlas mapping the associations of GLP-1RA spanning all organ systems,” said the study’s senior author, Ziyad Al-Aly, MD, a clinical ...

Researchers had found in a new study that sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 ...

While GLP-1RA drugs display effectiveness against a wide array of health problems, the magnitude of associated benefits is modest—about a 10 percent to 20 percent reduction for most outcomes.